POZEN Forms an Irish Subsidiary and Enters into an Intangible Property Transfer Arrangement

POZEN Inc. POZN, a pharmaceutical company committed to developing medicine that transforms lives, today announced that it has formed POZEN Limited, a wholly owned Irish subsidiary and has entered in an Intangible Property Transfer Arrangement between POZEN Inc. and POZEN Limited. The company has been evaluating its strategic options since recovering the U.S. commercial rights on YOSPRALA in November 2014 and recently announced hiring Adrian Adams as Chief Executive Officer and Andrew Koven as President and Chief Business Officer to lead the strategic effort. In anticipation of the approval and commercialization of YOSPRALA, the potential for significant global business and commercial activities and the expected financial benefits arising therefrom, the See full press release
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!